From The Jury

Texas Appeals Court Cuts $1M From Award But Weakens Learned Intermediary

CORPUS CHRISTI, Texas - A Texas appellate panel cut $1 million in future pain and anguish from a verdict of more than $4.6 million but dealt a blow to the learned intermediary doctrine in a case involving Centocor Inc.'s arthritis drug Remicade, saying in a March 4 opinion that direct-to-consumer (DTC) advertising along with changes in health care have undercut the doctrine's justification (Centocor Inc. v. Patricia Hamilton, et al., No. 13-07-00301-CV, Texas App., 13th Dist.; 2010 Tex. App. LEXIS 1623). Full story on lexis.com

Filed by admin at March 31st, 2010 under News